Designed to support your client service efforts and help grow your brokerage business, the guide can be accessed on the Broker Tools page.

Rising costs and the growing demand for health care — especially for hospital services and prescription drugs — are challenging patients, doctors, businesses, health plans, and the entire health care system. These difficulties are causing higher premiums and higher out-of-pocket costs nationwide.

Biosimilars represent an opportunity to improve access and affordability for our community. Excellus BlueCross BlueShield (BCBS) has advocated for the use of biosimilars since 2018 when we were the first standalone health plan to prefer a biosimilar in a major drug category. Today we include biosimilars in all drug categories in which biosimilars are available.